Safety of fruquintinib mono- and combo therapy in metastatic colorectal cancer: real-world subgroup analysis from China
- Published on 06/02/2026
- Reading time: 1 min.
Zhiqiang Wang a,* , Haijun Zhong b,* , Yifu He c , Chen Zhang d , Zuoxing Niu e , Shujun Yang f , Tao Zhang g , Liangjun Zhu h , Yongqian Shu i , Jianjun Peng j , Yan Song k , Jian Li l , Ying Yuan m , Haibo Zhang n , Gengsheng Yu o , Yunqi Hua p , Jianjun Xiao q , Jianfei Fu r , Yulong Zheng s , Jingyu Zhu t , Hua Xue t , Xian Luo t , Weiguo Su t , Shukui Qin u,* & Jin Li v,*
a State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China
b Department of Medical Oncology, Zhejiang Cancer Hospital, Hangzhou, China
c Department of Medical Oncology, Anhui Provincial Cancer Hospital, Hefei, China
d Department of Radiotherapy and Chemotherapy, Ningbo No.2 Hospital, Ningbo, China
e Department of Medical Oncology, Shandong Cancer Hospital, Shandong Academy of Medical Sciences, Jinan, China
f Department of Internal Medicine, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, China
g Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
h Department of Medical Oncology, Jiangsu Cancer Hospital, Nanjing, China
i Department of Medical Oncology, Jiangsu Province Hospital and Nanjing Medical University First Affiliated Hospital, Nanjing, China
j Center of Gastrointestinal Surgery, the First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China
k Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
l Department of Gastrointestinal Oncology, Peking University Cancer Hospital & Institute, Beijing, China
m Department of Medical Oncology, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
n Guangdong Provincial Hospital of Chinese Medicine, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangdong Provincial Academy of Chinese Medical Sciences, Guangzhou, China
o Department of Medical Oncology, Jiangmen Central Hospital, Jiangmen, China
p Department of Medical Oncology, Baotou Cancer Hospital, Baotou, China
q Department of Oncology, Zhongshan City People's Hospital, Zhongshan, China
r Department of Medical Oncology, Jinhua Central Hospital, Jinhua, China
s Department of Medical Oncology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
t
HUTCHMED Limited, Shanghai, China
u Gastrointestinal Cancer Center of Nanjing Tianyinshan Hospital, China Pharmaceutical University, Nanjing, China
v Department of Oncology, Shanghai GoBroad Cancer Hospital, China Pharmaceutical University, Shanghai, China
CONTACT Shukui Qin mailto:qinsk@csco.org Gastrointestinal Cancer Center of Nanjing Tianyinshan Hospital, China Pharmaceutical University, Nanjing
211100, China
Jin Li mailto:lijin@csco.org.cn Department of Oncology, Shanghai GoBroad Cancer Hospital, China Pharmaceutical University, Shanghai
201300, China
To continue reading this article in Full-Text...
Search | Advanced search
Get the latest news in Oncology
Receive our newsletter to stay up to date with the latest news in Oncology




